Objective. To translate the Fibromyalgia Impact Questionnaire (FIQ) into Ge
rman and to evaluate its reliability and validity for the use of German spe
aking patients with fibromyalgia (FM).
Methods. We administered the FIQ to 55 patients with FM (15 patients filled
out the questionnaire 10 days later) together with German versions of the
Stanford Health Assessment Questionnaire (HAQ), the Medical Outcomes Survey
Short Form-36 (SF-36). and a tender Feint count (TPC). All patients were a
sked about the severity of pain today (10 cm visual analog scale) and the d
uration of symptoms, Tenderness thresholds were assessed by dolorimetry at
all tender points with a Fisher dolorimeter and laboratory tests were obtai
ned. Test-retest reliability was assessed using Spearman correlations. Inte
rnal consistency was evaluated with Cronbach's alpha of reliability. Constr
uct validity of the FIQ was evaluated by correlating the HAQ and subscales
of the SF-36 as well its the TPC and the tenderness thresholds.
Results. Mean age of participants was 54.3 years and mean duration of sympt
oms 9.5 years. Test-retest reliability was between 0.62 and 1 for the physi
cal functioning as well Is fur the total FIQ and other components. Internal
consistency was 0.92 for the overall FIQ. Significant correlations were ob
tained between the FIQ items, the HAQ, and the SF-36.
Conclusion, The German FIQ is a reliable and valid instrument for measuring
functional disability and health status in German patients with FM.